The hereditary cancer working group from SEOM recommends prostate cancer screening with annual serum PSA measurements in male BRCA2 carriers starting at age 40, while this screening approach can also be offered to BRCA1 carriers [42]. This evidence concerns the gene BRCA2 and Familial prostate cancer.